Yahoo India Web Search

Sign In

Search results

  1. www.fosunpharma.com › enHome_Fosun Pharma

    Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"; stock code: 600196.SH, 02196.HK) is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China.

  2. en.wikipedia.org › wiki › Fosun_PharmaFosun Pharma - Wikipedia

    Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ( trade name: Fosun Pharma) is a Chinese pharmaceutical company. It is mostly owned by Fosun International. [2] As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. [3]

  3. www.fosunpharma.com › en › investorInvestor Relations_Fosun Pharma

    Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"; stock code: 600196.SH, 02196.HK) is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China.

  4. www.linkedin.com › company › fosunpharmaFosun Pharma | LinkedIn

    Fosun Pharma is patient-centered and clinical needs-oriented. The company continuously enriches its innovative product pipeline through independent research and development, cooperative...

  5. en.fosun.com › content › details46_4547Fosun Pharma 2021 Annual Results Announcement Accelerating the...

    Fosun Pharma has a strong innovative medicine pipeline. The New Drug Application (NDA) for the treatment of microsatellite instability-high (MSI-H) solid tumours has been accepted by the National Medical Products Administration (NMPA) with priority review.

  6. en.fosun.com › content › details46_4631Fosun Pharma Announces Results for the First Three Quarters of...

    Fosun Pharma directly operates businesses including pharmaceutical manufacturing, medical devices, medical diagnosis, and healthcare services. As a shareholder of Sinopharm Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business.

  7. en.fosun.com › content › details46_4617Fosun Pharma Announces 2022 Interim Results Stable Revenue Growth...

    Fosun Pharma Announces 2022 Interim Results Stable Revenue Growth and Recurring Income, Elevating the Revenue Contribution of New Products, and Accelerating International Layout

  8. www.prnewswire.com › news-releases › fosun-pharma-2021-annual-results-announcementFosun Pharma 2021 Annual Results Announcement: Accelerating the...

    Mar 22, 2022 · Fosun Pharma has a strong innovative medicine pipeline. The New Drug Application (NDA) for the treatment of microsatellite instability-high (MSI-H) solid tumours has been accepted by the...

  9. www.fosunpharma.com › en › aboutAbout Company_Our Company_Fosun Pharma

    Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"; stock code: 600196.SH, 02196.HK) is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China.

  10. www.fosunpharma.com › en › contentFosun Pharma Announces 2022 Annual Results: Achieved Steady...

    Fosun Pharma Announces 2022 Annual Results: Achieved Steady Growth with Revenue from Record High Innovative Products and Global Commercialization Capability Improvement. Performance Highlights: ·During the reporting period, the revenue was RMB 43.952 billion, with a year-on-year growth of12.66%; the net profit after deducting extraordinary ...